Literature DB >> 4986889

The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement.

S H Neoh, D Rowley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4986889     DOI： 10.1093/infdis/121.5.505

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  35 in total

1.  The effect of lysozyme on the complement-dependent bactericidal action of different antibody classes.

Authors:  R J Heddle; J Knop; E J Steele; D Rowley
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

2.  Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Authors:  Daniel T Leung; Mohammad Arif Rahman; M Mohasin; Sweta M Patel; Amena Aktar; Farhana Khanam; Taher Uddin; M Asrafuzzaman Riyadh; Amit Saha; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful Islam Khan; Richelle Charles; Regina LaRocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

3.  Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.

Authors:  R K Gupta; S C Szu; R A Finkelstein; J B Robbins
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

4.  Dog immunoglobulins. II. The antibacterial properties of dog IgA, IgM and IgG antibodies to Vibrio cholerae.

Authors:  R J Heddle; D Rowley
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

5.  Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.

Authors:  A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

6.  Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length.

Authors:  Peter Ftacek; Victor Nelson; Shousun C Szu
Journal:  Glycoconj J       Date:  2013-08-17       Impact factor: 2.916

7.  Suppression of growth of Vibrio cholerae in the intestine of immunized mice.

Authors:  J Knop; J E Bellamy
Journal:  Med Microbiol Immunol       Date:  1976-06-01       Impact factor: 3.402

8.  Human immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens.

Authors:  K Richardson; J B Kaper; M M Levine
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

9.  Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development.

Authors:  P A Manning; M W Heuzenroeder; J Yeadon; D I Leavesley; P R Reeves; D Rowley
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

10.  Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae.

Authors:  S D Sears; K Richardson; C Young; C D Parker; M M Levine
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.